dr donna h ryan glp-1 Today is World Obesity Day.🌎, According to @worldobesity, over 1 billion people worldwide are living with obesity, and projections show that 4 billion people are expected to be living with overweight FREE Webinar - The Obesity

Customization is also limited

This means companies can market products as GLP-1 mimetics or fat burners without providing scientific evidence, and without going through rigorous testing for safety or efficacy

Comparing Ozempic and Mounjaro SideBySide Ozempic : Proven GLP1 therapy with reliable appetite reduction and moderate weight loss Mounjaro : Dual-action GLP1/GIP therapy, delivering stronger metabolic impact and bigger weight loss Your health history, weight goals, and preferences guide the choice, so having both options available ensures you get the perfect fit

Breaking a weight-loss plateau with semaglutide

(Accessed 2025) for general background and side effect incidence from Phase 3 trials